Paper published in a journal (Scientific congresses and symposiums)
Bevacizumab for recurrent glioblastoma, early observations on patient outcome in the belgian medical need program
Duerinck, Johnny; Clement, Paul; Bouttens, F et al.
2012In Neuro-Oncology, 14 (3), p. 51
Peer Reviewed verified by ORBi
 

Files


Full Text
Bevacizumab for recurrent glioblastoma.pdf
Publisher postprint (793.44 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
neuro-oncology; bevacizumab; glioblastoma
Disciplines :
Oncology
Author, co-author :
Duerinck, Johnny;  UZ Brussels, Brussel, Belgium
Clement, Paul;  UZ Leuven, Leuven, Belgium
Bouttens, F;  AZ Sint-Lucas, Ghent, Belgium
Neyns, Bart;  UZ Brussels, Brussel, Belgium
D'Hondt, Lionel;  Cliniques Universitaires UCL de Mont Godinne, Yvoir, Belgium
GENNIGENS, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Staelens, Y;  Ziekenhuis Oost Limburg, Genk, Belgium
Joosens, Eric;  Jessa Ziekenhuis, Hasselt, Belgium
Van Fraeyenhove, F;  Middleheim Ziekenhuis, Antwerpen, Belgium
Rogiers, A;  Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten, Brussel, Belgium
Language :
English
Title :
Bevacizumab for recurrent glioblastoma, early observations on patient outcome in the belgian medical need program
Publication date :
September 2012
Event name :
10th Congress of the European-Association-of-NeuroOncology location
Event place :
Marseille, France
Event date :
Sept 06-09, 2012
Audience :
International
Journal title :
Neuro-Oncology
ISSN :
1522-8517
eISSN :
1523-5866
Publisher :
Duke University Press, Durham, United States - North Carolina
Volume :
14
Issue :
3
Pages :
51
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 20 January 2014

Statistics


Number of views
66 (5 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi